April 2015 Dr. Rudolph Tanzi is Director of the Genetics and Aging Research Unit at Massachusetts General Hospital and the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School. Dr. Tanzi co-discovered three of four known Alzheimer’s disease genes and directs the Alzheimer’s Genome Project, which has identified several other Alzheimer’s genes. He also co-discovered the Wilson’s disease gene and other neurological disease genes. He is co-founder of several biotech companies , including Prana Biotechnology, which has the promising Alzheimer’s drug, PBT2, in clinical trials. Dr. Tanzi has published over 450 papers and has received several awards, including the Metropolitan Life Foundation Award, Potamkin Prize, and one of the Top 100 Most Influential Harvard Alumni.